161Tb-SibuDAB

Terbium-161 labeled SibuDAB PSMA ligand · University Hospital Basel

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 161Tb-SibuDAB, covering 2024-08-14 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study [Phase 1]

See pricing